Home › Entities › doctoral_thesis › Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer

Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer

2017 doctoral thesis by Shevan Silva at University of Auckland
Place doctoral_thesis Q112200906
Press Enter · cited answer in seconds

Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer

Summary

Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer is a doctoral thesis[1].

Key Facts

  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer authored Potential for targeting wild-type EGFR in non-small cell lung cancer — author (P50): Shevan Silva[2].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's instance of is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — instance of (P31): doctoral thesis[3].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's publisher is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — publisher (P123): ResearchSpace@Auckland[4].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's country of origin is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — country of origin (P495): New Zealand[5].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's publication date is recorded as +2017-00-00T00:00:00Z[6].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's main subject is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — main subject (P921): biomedical sciences[7].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/36842[8].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's Handle ID is recorded as 2292/36842[9].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's title is recorded as Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer[10].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's copyright holder is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — copyright holder (P3931): Shevan Silva[11].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's thesis submitted to is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — thesis submitted to (P4101): University of Auckland[12].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's on focus list of Wikimedia project is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — on focus list of Wikimedia project (P5008): NZThesisProject[13].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's copyright status is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — copyright status (P6216): copyrighted[14].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's online access status is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — online access status (P6954): open access[15].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's thesis committee member is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — thesis committee member (P9161): Adam Patterson[16].
  • Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's thesis committee member is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — thesis committee member (P9161): Jeff Smaill[17].

Body

Designation and Status

Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer's instance of is recorded as Potential for targeting wild-type EGFR in non-small cell lung cancer — instance of (P31): doctoral thesis[3].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [2] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer. Retrieved May 3, 2026, from https://4ort.xyz/entity/mechanism-of-action-of-tarloxotinib-a-hypoxia-activated-pan-her-inhibitor-potential-for-targeting-wild-type-egfr-in-non-small-cell-lung-cancer
MLA “Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/mechanism-of-action-of-tarloxotinib-a-hypoxia-activated-pan-her-inhibitor-potential-for-targeting-wild-type-egfr-in-non-small-cell-lung-cancer.
BibTeX @misc{4ortxyz_mechanism-of-action-of-tarloxotinib-a-hypoxia-activated-pan-her-inhibitor-potential-for-targeting-wild-type-egfr-in-non-small-cell-lung-cancer_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer}}, year = {2026}, url = {https://4ort.xyz/entity/mechanism-of-action-of-tarloxotinib-a-hypoxia-activated-pan-her-inhibitor-potential-for-targeting-wild-type-egfr-in-non-small-cell-lung-cancer}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer — https://4ort.xyz/entity/mechanism-of-action-of-tarloxotinib-a-hypoxia-activated-pan-her-inhibitor-potential-for-targeting-wild-type-egfr-in-non-small-cell-lung-cancer (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/mechanism-of-action-of-tarloxotinib-a-hypoxia-activated-pan-her-inhibitor-potential-for-targeting-wild-type-egfr-in-non-small-cell-lung-cancer · Last refreshed: